The influence of Surelease and sodium alginate on the in-vitro release of tamsulosin hydrochloride in pellet dosage form

Journal of Pharmacy and Pharmacology

Volumn 57, Issue 6, 2005, Pages 735-742

  Kim, Min Soo ^a   Jun, Seoung Wook ^a   Lee, Sibeum ^a   Lee, Tae Wan ^a   Park, Jeong Sook ^a   Hwang, Sung Joo ^a  

^a Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; ETHYL CELLULOSE; MICROCRYSTALLINE CELLULOSE; POLYSORBATE 80; TAMSULOSIN;

ARTICLE; CONTROLLED DRUG RELEASE; DISPERSION; DISSOLUTION; DRUG DOSAGE FORM; PELLET EXTRUSION; PH; SCANNING ELECTRON MICROSCOPY; STOMACH JUICE; SURFACE PROPERTY;

ALGINATES; CELLULOSE; DELAYED-ACTION PREPARATIONS; GLUCURONIC ACID; HEXURONIC ACIDS; HYDROGEN-ION CONCENTRATION; KINETICS; SOLUBILITY; SULFONAMIDES; SURFACE PROPERTIES;

EID: 18844379446     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357056316     Document Type: Article

References (39)

1. Beduschi, M. C., Beduschi, R., Oesterling, J. E. (1998) Alpha-blockade therapy for benign prostatic hyperplasia: from a nonselective to a more selective alpha1A-adrenergic antagonist. Urology 51: 861-872
2. Bodmeier, R., Paeratakul, O. (1991) Process and formulation variables affecting the drug release from chlorpheniramine maleate-loaded beads coated with commercial and self-prepared aqueous ethyl cellulose pseudolatexes. Int. J. Pharm. 70: 59-68
3. Bodmeier, R., Paeratakul, O. (1994) The effect of curing on drug release and morphological properties of ethylcellulose pseudolatex-coated beads. Drug Dev. Ind. Pharm. 20: 1517-1533
4. Brazel, C. S., Peppas, N. A. (2000) Modeling of drug release from swellable polymers. Eur. J. Pharm. Biopharm. 49: 47-58
5. Chapple, C., Andersson, K. E. (2002) Tamsulosin: an overview. World J. Urol. 19: 397-404
6. Chatchawalsaisin, J., Podczeck, F., Newton, J. M. (2004) The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation. Int. J. Pharm. 275: 41-60
7. Chatlapalli, R., Rohera, B. D. (1998) Physical characterization of HPMC and HEC and investigation of their use as pelletization aids. Int. J. Pharm. 161: 179-193
8. Christensen, L. A. (2000) 5-Aminosalicylic acid containing drugs. Dan. Med. Bull. 47: 20-41
9. Costa, P., Manuel, J., Lobo, S. (2001) Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 13: 123-133
10. David, F. E. (1997) Extrusion-spheronization for granulation. In: Parikh, D. M. (ed.) Handbook of pharmaceutical granulation technology. Marcel Dekker, New York, pp 333-368
11. FDA Guidance for Industry (1997a) Dissolution testing of immediate release solid oral dosage forms. Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, MD, August
12. FDA Guidance for Industry (1997b) SUPAC-MR: modified release solid oral dosage forms scale-up and postapproval changes: chemistry, manufacturing, and controls. In vitro dissolution testing and in vivo bioequivalence documentation. Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, MD, September
13. Frohoff-Hulsmann, M. A., Schmitz, A., Lippold, B. C. (1999) Aqueous ethyl cellulose dispersions containing plasticizers of different water solubility and hydroxypropyl methylcellulose as coating material for diffusion pellets. I. Drug release rates from coated pellets. Int. J. Pharm. 177: 69-82
14. Gandhi, R., Lal Kaul, C., Panchagnula, R. (1999) Extrusion and spheronization in the development of oral controlled-release dosage forms. Pharm. Sci. Technol. Today 4: 160-170
15. Ghebre-Sellassie, I. (1989) Pellet: a general overview. In: Ghebre-Sellassie, I. (ed.) Pharmacetical pelletization technology. Marcel Dekker, New York, pp 1-13
16. Hodsdon, A. C., Mitchell, J. R., Davies, M. C., Melia, C. D. (1995) Structure and behaviour in hydrophilic matrix sustained release dosage forms: 3. The influence of pH on the sustained-release performance and internal gel structure of sodium alginate matrices. J. Control. Release 33: 143-152
17. Iyer, R. M., Augsburger, L. L., Parikh, D. M. (1993) Evaluation of drug layering and coating: effect of process mode and binder level. Drug Dev. Ind. Pharm. 19: 981-998
18. Kervinen, L., Ylirusi, J. (1993) Modelling S-shaped dissolution curves. Int. J. Pharm. 92: 115-122
19. Klotz, U. (1999) Pharmacokinetic properties of various preparations of 5-aminosalicylic acid (5-AS) and budesonide. Med. Klin. 94: S16-S22
20. Klotz, U., Schwab, M. (2005) Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease. Adv. Drug Deliv. Rev. 57: 267-279
21. Korsmeyer, R. W., Gurny, R., Doelker, E., Buri, P., Peppas, N. A. (1983) Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 15: 25-35
22. Maganti, L., Celik, M. (1994) Compaction studies on pellets: II. Coated pellets. Int. J. Pharm. 103: 55-67
23. Majid Khan, G., Jiabi, Z. (1998) Formulation and in vitro evaluation of ibuprofen-Carbopol 974P-NF controlled release matrix tablets. III: Influence of co-excipients on release rate of the drug. J. Control. Release 54: 185-190
24. Majid Khan, G., Zhu, J. B. (1998) Ibuprofen release kinetics from controlled-release tablets granulated with aqueous polymeric dispersion of ethylcellulose. II: Influence of several parameters and coexcipients. J. Control. Release 56: 127-134
25. Moore, J. W., Flanner, H. H. (1996) Mathematical comparison of dissolution profiles. Pharm. Technol. 20: 64-75
26. O'Leary, M. P. (2001) Tamsulosin: current clinical experience. Urology 58: 42-48
27. Ozturk, A. G., Ozturk, S. S., Palsson, B. O., Wheatley, T. A., Dressman J. B. (1990) Mechanism of release from pellets coated with an ethylcellulose-based film. J. Control. Release 14: 203-213
28. Pearnchob, N., Bodmeier, R. (2003) Dry polymer powder coating and comparison with conventional liquid-based coatings for Eudragit RS, ethylcellulose and shellac. Eur. J. Pharm. Biopharm. 56: 363-369
29. Porter, S. C. (1989) Controlled-release film coatings based on ethylcellulose. Drug Dev. Ind. Pharm. 15: 1495-1521
30. Rao, K. V. R., Devi, K. P., Buri, P. (1988) Cellulose matrices for zero-order release of soluble drugs. Drug Dev. Ind. Pharm. 14: 2299-2320
31. Sadeghi, F., Ford, J. L., Rubinstein, M. H., Rajabi-Siahboomi, A. R. (2000) Comparative study of drug release from pellets coated with HPMC or Surelease. Drug Dev. Ind. Pharm. 26: 651-660
32. Sadeghi, F., Ford, J. L., Rubinstein, M. H., Rajabi-Siahboomi, A. R. (2001) Study of drug release from pellets coated with Surelease containing hydroxypropylmethylcellulose. Drug Dev. Ind. Pharm. 27: 419-430
33. Sadeghi, F., Ford, J. L., Rajabi-Siahboomi, A. (2003) The influence of drug type on the release profiles from Surelease-coated pellets. Int. J. Pharm. 254: 123-135
34. Sarisuta, N., Punpreuk, K. (1994) In vitro properties of film-coated diltiazem hydrochloride pellets compressed into tablets. J. Control. Release 31: 215-222
35. Tonnesen, H. H., Karlsen, J. (2002) Alginate in drug delivery systems. Drug Dev. Ind. Pharm. 28: 621-630
36. Tromm, A., Griga T., May, B. (1999) Oral mesalazine for the treatment of Crohn's disease: clinical efficacy with respect to pharmacokinetic properties. Hepato-Gastroenterology 46: 3124-3135
37. Wilde, M. I., McTavish, D. (1996) Tamsulosin: a review of its pharmacological properties and therapeutic potential in the management of symptomatic benign prostatic hyperplasia. Drugs 52: 883-898
38. Yuen, K. H., Desmukh, A. A., Newton, J. M. (1993) Development and in vitro evaluation of a multiparticulate sustained release theophylline formulation. Drug Dev. Ind. Pharm. 19: 855-874
39. Yuksel, N., Kanik, A. E., Baykara, T. (2000) Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and -independent methods. Int. J. Pharm. 209: 57-67